Greenspring Associates’s Veracyte VCYT Stock Holding History

Greenspring Associates’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,652	Closed	-$160K	–	20
2019 Q3	$160K	Buy	+6,652	New	+$177K	0.05%	13

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Greenspring Associates's VCYT Position: Q4 2019 in Review

Greenspring Associates sold out of Veracyte (VCYT) in Q4 2019, closing a stake of 6,652 shares — an estimated $160K sold.

Greenspring Associates first reported a position in VCYT in Q3 2019 and held it in 1 quarter. The position peaked at $160K in Q3 2019. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.

Greenspring Associates reported no remaining Veracyte position as of Q4 2019 after selling out during the quarter.
Greenspring Associates sold 6,652 Veracyte shares in Q4 2019, an estimated $160K.
Greenspring Associates first reported a position in Veracyte in Q3 2019 and held it in 1 quarter.
Greenspring Associates's Veracyte position peaked at $160K in Q3 2019.
179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.

Based on Greenspring Associates's 13F filing for Q4 2019, filed 14 Feb 2020.